Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data
暂无分享,去创建一个
R. Suzuki | T. Nakazato | K. Izutsu | M. Yamaguchi | Y. Imaizumi | J. Suzumiya | K. Shimada | N. Fukuhara | S. Matsuda | N. Tomita | K. Miyazaki | Tsutomu Takahashi | Y. Suehiro | I. Yoshida